Hospital Infection Prevention a Growth Market
Hospital infection prevention a growth market around the world.The latest market report published by Credence Research, Inc. “Hospital Infection Prevention and Control Market – Growth, Future Prospects, and Competitive Analysis, 2016 – 2024,” the global hospital infection prevention and control market was valued at $146.6 Million in 2015, and is expected to reach $245.6 Million by 2024, expanding at a rate of 6.3% from 2016 to 2024.
The market experts suggest that healthcare associated infections are a costly issue faced by all hospitals across the globe. Hospital acquired infections are type of infections that are observed in patients during the course of receiving treatment for unrelated conditions. According to the World Health Organization (WHO), infectious waste contributes in this way to the risk of nosocomial infections, putting the health of hospital personnel, and patients, at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences each year, surgical site infections (SSI) are the second most prevalent in the United States, preceded only by urinary tract infections. At a cost of approximately $10 Billion annually, this high incidence of SSI’s significantly impacts the U.S. healthcare system, as well as the bottom line of individual hospitals.
The occurrence of nosocomial infections has been observed worldwide in both developed and resource-poor countries. Key factors assisting the growth of hospital infections prevention and control market are rising prevalence of infections, implementation of stringent guidelines associated with hospital infection prevention and control, developing healthcare infrastructure in emerging countries, and rising number of hospitals across the world.
The global hospital infection prevention and control market is segmented by infection type as pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA and others. These are the major types of hospital acquired infections that find the highest prevalence. As sourced from the CDC, ventilator associated pneumonia and surgical site infection are the most common conditions followed by GI infection, UTI, and primary blood stream infection.
Global Hospital Infection Prevention and Control Market are segmented by Product type as Infection Prevention Supplies, Infection Prevention Equipment and Infection Prevention Services. Infection prevention supplies held the largest share in the overall hospital infection prevention and control market.
Based on the therapeutic application type, the global hospital infection prevention and control market is segmented as follows:
Infection Prevention Supplies
Protective Apparel & Textiles
Safety-Enhanced Medical Devices
Medical Waste Disposal Supplies
Infection Prevention Equipment
Other Infection Prevention Equipment
Infection Prevention Services
Other Infection Prevention Equipment
As of the current market scenario, North America formed the largest market for hospital infection prevention and control market due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. Asia Pacific is the fastest growing segment with an increase in awareness of the healthcare associated infection. Rising investment in health care infrastructure, technological advancement and new protocols and programs conducted for infection prevention and control in line with WHO guidelines are being used on a more regular basis.
A growing issue of preventable disease burden in respect of morbidity and mortality in all countries. Nosocomial infection is major cause of concern for the patient and as well as the health care providers. The rising prevalence of the nosocomial infection is major driving factor for hospital infection and prevention market.
WHO and various others regulatory bodies at regional and national level provide guidelines for hospital infection prevention and control. The significant steps taken to control infection include to identify patients at risk of nosocomial infection, maintaining the hand hygiene, practicing standard precautionary measure to reduce the transmission and applying novel strategies to reduce VAP, CR-BSI, and CAUTI.
In emerging economies, there is rise in R&D and increase government initiative in health care sector.
Reducing hospital related infections is good for the patient and it is one area where hospitals can reduce cost while improving the quality of care.
If you enjoyed this article please like and share it.